Trial Profile
A randomized double-blind, placebo-controlled, crossover study to assess the reproducibility and the effect of gabapentin on quantitative sensory testing in neuropathic pain patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2021
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Pfizer; Viatris Inc
- 02 Jun 2008 New trial record.